A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Asthma
Interventions
DRUG

ipratropium plus salbutamol UDV

DRUG

salbutamol UDV

Trial Locations (10)

1104

Philippine Children's Medical Center, Quezon

Unknown

Jose Reyes Memorial Medical Center, Manila

Philippine General Hospital, Manila

Amang Rodriguez Hospital, Marikina City

San Juan de Dios Hospital, Pasay

Rizal Provincial Hospital, Pasig

Quezon City General Hospital, Quezon

East Ave Medical Center, Quezon City

Philipines Heart Center, Quezon City

Quirino Memorial Medical Center, Quezon City

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY